EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Efficacy of Ambulatory Intravenous Diuresis for Chronic Heart Failure Patients: Insights from the DEA-HF Trial

Amit Gruber, Aharon Ronnie Abbo, Ina Volis, Doron Aronson, Nicolas Girerd, Søren Lund Kristensen, Robert Zukermann, Natalia Alberkant, Elena Sitnitsky, Anton Kruger, Polina Khasis, Evgeny Bravo und 3 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15358 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Amit Gruber und 14 weiteren Autor:innen. Beteiligte Einrichtung: From the Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Ambulatory Care, Diuresis, Furosemide, Heart Failure. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Oral diuretic treatment has limited efficacy in managing chronic heart failure (HF) patients. Novel strategies are needed to manage patients with refractory congestion despite optimal HF therapy and high-dose oral diuretic treatment. In the present study, we prospectively quantified the efficacy and safety of an ambulatory, weekly, high-dose parenteral diuresis strategy. Methods and results Data from the prospective, randomized, cross-over controlled study for comparisons of diuresis efficacy in HF patients (DEA-HF) were analysed. Chronic HF patients with congestion despite guideline-directed medical therapy were enrolled to receive three high-intensity diuretic regimens, once a week, in a randomized order: intravenous (IV) furosemide 250 mg; IV furosemide 250 mg + oral metolazone 5 mg; and IV furosemide 250 mg + IV acetazolamide 500 mg. The primary outcome compared the total sodium excretion following each diuretic regimen. Here, all regimens were pooled to assess the effect of weekly intensive diuresis approach on congestion parameters. The study population included 42 patients, 40% females, with a mean age of 72 ± 9 years. Following three consecutive weekly treatments, the mean body weight was decreased from 85.5 kg [95% confidence interval (CI): 79.7–91.2] to 83.1 kg (95% CI: 77.4–88.9. P = 0.0005), accompanied by a significant decrease in congestion score, N-terminal-pro-brain natriuretic peptide levels and lung ultrasound B-line count. Serum creatinine mildly but significantly increased from 1.81 mg/dL (95% CI: 1.62–2.01) to 2.01 mg/dL (95% CI: 1.81–2.21. P < 0.001), and no hospitalizations due to acute kidney injury occurred.

Conclusions

In patients with congestion-refractory HF, an ambulatory strategy utilizing high-intensity weekly IV diuretic therapy achieved effective decongestion without major safety concerns. This escalated strategy may improve clinical outcomes and prevent hospitalizations of chronic HF patients who require diuresis intensification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ambulatory CareDiuresisFurosemideHeart FailureAgedFemaleHumansMaleMiddle AgedAcetazolamideAdministration, IntravenousChronic DiseaseCross-Over StudiesDiureticsDose-Response Relationship, DrugFollow-Up StudiesInfusions, IntravenousMetolazoneProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

congestionday‐carediureticsheart failure

Substanzen

AcetazolamideDiureticsFurosemideMetolazone

Autor:innen und Institutionen

  • From the Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa, Israel.
  • Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Université de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, CHRU Nancy, INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
  • Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Clinical Research Institute at Rambam (CRIR), Haifa, Israel.

Zitieren

APA

Gruber, A., Abbo, A. R., Volis, I., Aronson, D., Girerd, N., Kristensen, S. L., Zukermann, R., Alberkant, N., Sitnitsky, E., Kruger, A., Khasis, P., Bravo, E., Elad, B., Levin, L. H., & Caspi, O. (2025). Efficacy of Ambulatory Intravenous Diuresis for Chronic Heart Failure Patients: Insights from the DEA-HF Trial. ESC Heart Failure. https://doi.org/10.1002/ehf2.15358

Vancouver

Gruber A, Abbo AR, Volis I, Aronson D, Girerd N, Kristensen SL, et al. Efficacy of Ambulatory Intravenous Diuresis for Chronic Heart Failure Patients: Insights from the DEA-HF Trial. ESC Heart Failure. 2025. doi:10.1002/ehf2.15358

BibTeX
@article{Gruber2025,
  author = {Gruber, Amit and Abbo, Aharon Ronnie and Volis, Ina and Aronson, Doron and Girerd, Nicolas and Kristensen, Søren Lund and Zukermann, Robert and Alberkant, Natalia and Sitnitsky, Elena and Kruger, Anton and Khasis, Polina and Bravo, Evgeny and Elad, Boaz and Levin, Ludmila Helmer and Caspi, Oren},
  title = {Efficacy of Ambulatory Intravenous Diuresis for Chronic Heart Failure Patients: Insights from the DEA-HF Trial},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15358}
}
Kostenlos starten →